References
- World Health Organization. WHO Coronavirus (COVID-19) dashboard.
Accessed on 6 June 2022.
https://covid19.who.int/
- Araf Y, Akter F, Tang Y, et al. Omicron variant of SARS‐CoV‐2:
Genomics, transmissibility, and responses to current Covid‐19
Vaccines. J Med Virol . 2022;94(5):1825-1832.
- Abdullah F, Myers J, Basu D, et al. Decreased severity of disease
during the first global omicron variant covid-19 outbreak in a large
hospital in Tshwane, South Africa. Int J Infect Dis .
2022;116:38-42.
- Sigal A. Milder disease with Omicron: Is it the virus or the
pre-existing immunity? Nat Rev Immunol . 2022;22(2):69-71.
- Lim HJ, Jung HS, Park MY, Baek YH, Kannappan B, Park JY, Yang JH, Seol
JH, Lee MW, et al. Evaluation of three automated extraction systems
for the detection of SARS-CoV-2 from clinical respiratory specimens.Life . 2022;12(1):68.
- Kumar S, Lomash A, Faruq M, et al. Amplicon-based nanopore minion
sequencing of patients with COVID-19 omicron variant from India.
medRxiv; 2021. Published online 30 December 2021.
- Ledford H. How severe are omicron infections? Nature .
2021;600(7890):577-578.
- Menni C, Valdes AM, Polidori L, et al. Symptom prevalence, duration,
and risk of hospital admission in individuals infected with SARS-CoV-2
during periods of Omicron and Delta variant dominance: A prospective
observational study from the Zoe Covid Study. Lancet .
2022;399(10335):1618-1624.
- Greaney AJ, Starr TN, Gilchuk P, et al. Complete mapping of mutations
to the SARS-CoV-2 spike receptor-binding domain that escape antibody
recognition. Cell Host Microbe. 2021;29:44–57.
- Kim M-K, Lee B, Choi YY, et al. Clinical characteristics of 40
patients infected with the SARS-CoV-2 omicron variant in Korea.J Korean Med Sci. 2022;37:e31.
- Maslo C, Friedland R, Toubkin M, Laubscher A, Akaloo T, Kama B.
Characteristics and outcomes of hospitalized patients in South Africa
during the COVID-19 omicron wave compared with previous waves.JAMA . 2022;327:583–84.
- Nyberg T, Ferguson NM, Nash SG, Webster HH, Flaxman S, et al.
Comparative analysis of the risks of hospitalisation and death
associated with SARS-CoV-2 omicron (B. 1.1. 529) and delta (B. 1.617.
2) variants in England: a cohort study. Lancet .
2022;399(10332):1303-12.
- Covid-19 vaccination in India. Wikipedia. Accessed December 14, 2022.
https://en.wikipedia.org/wiki/COVID-19_vaccination_in_India.
- Thomas A.L., Alarcon P.C., Divanovic S., Chougnet C.A., Hildeman D.A.,
Moreno-Fernandez M.E. Implications of inflammatory states on
dysfunctional immune responses in aging and obesity. Front
Aging. 2021;2(42).
- Daryabor G, Atashzar MR, Kabelitz D, Meri S, Kalantar K. The effects
of type 2 diabetes mellitus on organ metabolism and the immune system.Front Immunol . 2020;11:1582.
- Fourati S., Cristescu R., Loboda A., Talla A., Filali A., Railkar R.,
et al. Pre-vaccination inflammation and B-cell signalling predict
age-related hyporesponse to hepatitis B vaccination. Nat
Commun. 2016;7(1):1-2.
- Iyonaga T., Shinohara K., Mastuura T., Hirooka Y., Tsutsui H. Brain
perivascular macrophages contribute to the development of hypertension
in stroke-prone spontaneously hypertensive rats via sympathetic
activation. Hypertens Res. 2020;43(2):99–110.
- Soegiarto G, Wulandari L, Purnomosari D, Fahmita KD, Gautama HI,
Hadmoko ST, Prasetyo ME, Mahdi BA, et al. Hypertension is associated
with antibody response and breakthrough infection in health care
workers following vaccination with inactivated SARS-CoV-2.Vaccine. 2022;40(30):4046-4056.
- Boroumand AB, Forouhi M, Karimi F, Moghadam AS, Naeini LG, Kokabian P,
Naderi D. Immunogenicity of COVID-19 vaccines in patients with
diabetes mellitus: A systematic review. Front Immunol .
2022;13:940357.
- Ahmad Malik J, Ahmed S, Shinde M, et al. The impact of covid-19 on
Comorbidities: A review of recent updates for combating it.Saudi J Biol Sci . 2022;29(5):3586-3599.
- Lippi G, Wong J, Henry BM. Hypertension and its severity or mortality
in coronavirus disease 2019 (covid-19): A pooled analysis.Polish Arch Intern Med . 2020;130:304-309.
- Barron E, Bakhai C, Kar P, Weaver A, Bradley D, Ismail H, Knighton P,
Holman N, Khunti K, Sattar N, et al. Associations of Type 1 and Type 2
Diabetes with COVID-19-Related Mortality in England: A
Whole-Population Study. Lancet Diabetes Endocrinol .
2020;8;813–822.
- Wang T, Du Z, Zhu F, Cao Z, An Y, Gao Y, Jiang B. Comorbidities and
multi-organ injuries in the treatment of COVID-19. Lancet .
2020;395(10228):e52.
- Guo W, Li M, Dong Y, Zhou H, Zhang Z, Tian C, Qin R, Wang H, Shen Y,
Du K, Zhao L, Fan H, Luo S, Hu D. Diabetes is a risk factor for the
progression and prognosis of COVID-19. Diabetes Metab Res Rev .
2020;e3319.
- The GISAID initiative. GISAID—hCov19 variants. Accessed June 12,
2022. https://www. gisaid.org/hcov19-variants.
- Hui KP, Ho JC, Cheung M, et al. SARS-CoV-2 omicron variant replication
in human Bronchus and lung ex vivo. Nature .
2022;603(7902):715-720.
- Wang W, Xu Y, Gao R, et al. Detection of SARS-CoV-2 in different types
of clinical specimens. JAMA. 2020;323(18):1843-1844.
- Diao B, Wang C, Wang R, Feng Z, Zhang J, Yang H, Tan Y, Wang H, Wang
C, Liu L, Liu Y. Human kidney is a target for novel severe acute
respiratory syndrome coronavirus 2 infection. Nat Commun .
2021;12(1):1-9.
- Wolter N, Jassat W, Walaza S, et al. Early assessment of the clinical
severity of the SARS-CoV-2 omicron variant in South Africa: a data
linkage study. Lancet 2022; 399: 437–46.
- Zhang J, Dong X, Cao Y, et al. Clinical characteristics of 140
patients infected with SARS‐CoV‐2 in Wuhan, China. Allergy .
2020;75(7):1730-1741.
- Zhou F, Yu T, Du R, et al. Clinical course and risk factors for
mortality of adult inpatients with covid-19 in Wuhan, China: A
retrospective cohort study. Lancet . 2020;395(10229):1054-1062.
- Liu W, Tao ZW, Lei W, et al. Analysis of factors associated with
disease outcomes in hospitalised patients with 2019 novel coronavirus
disease. Chin Med J (Engl). 2020;133(9):1032-1038.
- Guan WJ, Ni ZY, Hu Y, et al. Clinical characteristics of coronavirus
disease 2019 in China. N Engl J Med. 2020;382(18):1708-1720.
- Vardavas C, Nikitara K. Covid-19 and smoking: A systematic review of
the evidence. Tob Induc Dis . 2020;18:20.
- Cascella M, Rajnik M, Aleem A, Dulebohn SC, Di Napoli R. Features,
Evaluation, and Treatment of Coronavirus (COVID-19).
In: StatPearls . Treasure Island (FL): StatPearls Publishing;
October 13, 2022
- Baud D, Qi X, Nielsen-Saines K, Musso D, Pomar L, Favre G. Real
estimates of mortality following COVID-19 infection. Lancet
Infect Dis . 2020;20(7):773.